Back to Search Start Over

Antihistamines in Pregnancy

Authors :
Javad Ghaffari
Source :
Journal of Pediatrics Review, Vol 11, Iss 4, Pp 289-292 (2023)
Publication Year :
2023
Publisher :
Mazandaran University of Medical Sciences, 2023.

Abstract

Allergic disorders are increasing prevalence from decades. Often of allergic diseases such as chronic urticaria in some aspects of quality of life of patients affected. Outdoor and indoor allergens can cause aggravation of symptoms in allergic patients. H1-antihistamines have been available for decades and those are over-the-counter drugs. The first generation H1-antihistamines have anticholinergic and sedative effects. Basically, their use (H1 blockers) for the routine management of allergic diseases is not recommended. Second generation H1-antihistamines (bilastine, cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, and rupatadine) have minimally or non-sedating and free of anticholinergic effects. About 10–15% of pregnant women used antihistamine within pregnancy.

Details

Language :
English
ISSN :
23224398 and 23224401
Volume :
11
Issue :
4
Database :
Directory of Open Access Journals
Journal :
Journal of Pediatrics Review
Publication Type :
Academic Journal
Accession number :
edsdoj.29f0d5b4b2e14ffbbf9aaecb6c5b0727
Document Type :
article